SCHEMBL4191185

SCHEMBL4191185

CC(=COc1cccc2ccccc12)C(=O)OCCCOc1ccc(-c2ccccc2OCCCOC(=O)C(C)=COc2cccc3ccccc23)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNA3 P22001 1/20 0.43
FFAR4 Q5NUL3 2/20 0.41
MCL1 Q07820 4/20 0.41
KDM4E B2RXH2 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
CHRNB4 P30926 1/20 0.40
CHRNA3 P32297 1/20 0.40
CHRNA7 P36544 1/20 0.40
PPARG P37231 2/20 0.39
PPARA Q07869 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
SLC6A4 P31645 2/20 0.39
HRH1 P35367 1/20 0.39
MMP3 P08254 1/20 0.39
BAD Q92934 1/20 0.38
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4197515 0.93 KCNA3 (0.44) KCNA3KDM4EALDH1A1HPGDPPARG
SCHEMBL4191430 0.92 KCNA3 (0.47) KCNA3KDM4EALDH1A1HPGDMEN1
SCHEMBL4204685 0.91 ALDH1A1 (0.46) KCNA3MCL1KDM4EALDH1A1HPGD
SCHEMBL4186160 0.89 FFAR4 (0.47) FFAR4KDM4EALDH1A1MEN1KMT2A
SCHEMBL4202076 0.87 ALDH1A1 (0.49) KCNA3MCL1KDM4EALDH1A1HPGD
SCHEMBL4198178 0.87 FFAR4 (0.42) FFAR4KDM4EALDH1A1PPARGPPARA
SCHEMBL4188678 0.85 FFAR4 (0.46) FFAR4KDM4EALDH1A1PPARGPPARA
SCHEMBL4194788 0.85 KCNA3 (0.45) KCNA3KDM4EALDH1A1HPGDMEN1
SCHEMBL4197503 0.85 FFAR4 (0.48) FFAR4KDM4EALDH1A1PPARGPPARA
SCHEMBL4197864 0.85 FFAR4 (0.47) FFAR4KDM4EALDH1A1PPARGPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1627867-B1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF MITSUI CHEMICALS INC (JP) 2016-01-20 EP disclosed
US-7534909-B2 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2009-05-19 US disclosed
US-20070078198-A1 (Meth) acrylic ester compound and use thereof MITSUI CHEMICALS, INC. (JP) 2007-04-05 US disclosed
EP-1627867-A1 (METH)ACRYLIC ESTER COMPOUND AND USE THEREOF Mitsui Chemicals, Inc. (JP) 2006-02-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070078198-A1 (Meth) acrylic ester compound and use thereof METTL14, PAM, TAS2R41 KCNA3 2553/4885FFAR4 1889/4885MCL1 3198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.